| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/17/2004 | US6776989 Intratracheal administration of lysozyme |
| 08/17/2004 | US6776986 Nucleic acid sequence which, when generates mrna which anneals with mrna stranscrip from hiv-1 provirus encoding env, pol, and/or gag proteins |
| 08/17/2004 | US6776984 Administering of thrombopoietin to induce endogenous production of platelet-derived growth factor; systemically administering thyroid hormone to control cell division and oligodendroglia production |
| 08/17/2004 | US6776983 Protein free formulations |
| 08/17/2004 | US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/17/2004 | CA2325371C Method of increasing bone toughness and stiffness and reducing fractures |
| 08/17/2004 | CA2258153C Hepatocyte growth factor receptor agonists and uses thereof |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/12/2004 | WO2004068135A2 Identification and modification of immunodominant epitopes in polypeptides |
| 08/12/2004 | WO2004068109A2 Autologous or homologous coagulant produced from anticoagulated whole blood |
| 08/12/2004 | WO2004067762A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 08/12/2004 | WO2004067753A2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
| 08/12/2004 | WO2004067752A1 Paramyxovirus vector encoding ribozyme and utilization thereof |
| 08/12/2004 | WO2004067741A1 Transcriptional activator |
| 08/12/2004 | WO2004067736A2 Custom-made meganuclease and use thereof |
| 08/12/2004 | WO2004067735A1 Human genic recombination lysozyme it’s a new use about preparation anti-bacteria resistant drug |
| 08/12/2004 | WO2004067719A2 Growth hormone releasing hormone (ghrh) for use in reducing culling in herd animals |
| 08/12/2004 | WO2004067717A2 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 08/12/2004 | WO2004067712A2 Intracellular signaling molecules |
| 08/12/2004 | WO2004067704A2 Freeze-dried fibrin matrices and methods for preparation thereof |
| 08/12/2004 | WO2004067698A2 Helminth-derived antigens having capacity of providing protection against parasites |
| 08/12/2004 | WO2004067563A1 Peptide inhibitors of toxins derived from ll-37 |
| 08/12/2004 | WO2004067561A1 Amyloid-$g(b)(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 08/12/2004 | WO2004067560A2 Herpes simplex vp16 protein binding polypeptides |
| 08/12/2004 | WO2004067559A1 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria |
| 08/12/2004 | WO2004067558A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | WO2004067549A2 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 08/12/2004 | WO2004067028A1 Compound for attenuating reaction of recipient tissues to an exogenic material and method for preparing an implant/transplant for contacting tissues of the organism of said recipient |
| 08/12/2004 | WO2004067027A2 Osteogenic composition |
| 08/12/2004 | WO2004067026A1 Regulation of allergen induced gene |
| 08/12/2004 | WO2004067025A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
| 08/12/2004 | WO2004067024A2 Hcv combination therapy |
| 08/12/2004 | WO2004067023A2 Survivin-derived peptides and use thereof |
| 08/12/2004 | WO2004067022A2 Use of a mixture containing neuropeptides and steroids for treating disturbances of psychosocial experiences and behaviour |
| 08/12/2004 | WO2004067021A1 Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges |
| 08/12/2004 | WO2004067020A1 Dna vaccine composition with enhanced immunogenicity |
| 08/12/2004 | WO2004066995A1 Method for treating ischemic stroke with melatonin |
| 08/12/2004 | WO2004066989A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide comp lexes |
| 08/12/2004 | WO2004066966A2 Peptide yy analogs |
| 08/12/2004 | WO2004066963A2 N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| 08/12/2004 | WO2004066958A2 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 08/12/2004 | WO2004066956A2 Uses of integrin alphavbeta3 antagonists |
| 08/12/2004 | WO2004066953A2 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 08/12/2004 | WO2004066947A2 Hyperthermia oncolysis co-therapy |
| 08/12/2004 | WO2004066932A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066931A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066914A2 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | WO2004066704A2 Injectable hydrogel microspheres from aqueous two-phase system |
| 08/12/2004 | WO2004056384A3 Use of factor vii polypeptides for preventing formation of inhibitors to blood coagulation factor viii and ix |
| 08/12/2004 | WO2004056347A3 Pharmaceutical compositions comprising insulin and legends of insulin hexamer |
| 08/12/2004 | WO2004053061A8 Methods of therapy and diagnosis using targeting of cells that express lax |
| 08/12/2004 | WO2004050037A3 Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease |
| 08/12/2004 | WO2004046166A3 Modified alpha-msh peptides and derivatives thereof |
| 08/12/2004 | WO2004046070A3 Modulation of proteins by phenolic compoudns |
| 08/12/2004 | WO2004045593A3 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 08/12/2004 | WO2004045530A3 Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors |
| 08/12/2004 | WO2004043374A3 Methods and compositions for treating cancer using proteasome inhibitors |
| 08/12/2004 | WO2004041182A3 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 08/12/2004 | WO2004033691A3 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 08/12/2004 | WO2004032880A3 Method for inhibiting angiogenesis with ship-1 inhibitors |
| 08/12/2004 | WO2004032789A3 Liposomal hgh composition and method for administration thereof |
| 08/12/2004 | WO2004031374A3 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 08/12/2004 | WO2004029201A3 Peptide derivative fusion inhibitors of hiv infection |
| 08/12/2004 | WO2004029074A3 Hiv-derived hr1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 08/12/2004 | WO2004029073A3 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 08/12/2004 | WO2004027062A3 Functional correction of the -786c/t variance of the human enos gene |
| 08/12/2004 | WO2004026895A3 Gd2 ligands |
| 08/12/2004 | WO2004026814A3 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 08/12/2004 | WO2004018676A3 Rnai probes targeting cancer-related proteins |
| 08/12/2004 | WO2004015131A3 Hepatitis c virus assays |
| 08/12/2004 | WO2004013289A9 Diagnosis of kidney damage and protection against same |
| 08/12/2004 | WO2004009024A3 Modulation of protein kinase c-iota expression |
| 08/12/2004 | WO2004003561A9 Peptide rod amphiphiles and self-assembly of same |
| 08/12/2004 | WO2004002999A3 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 08/12/2004 | WO2003103592A3 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003071927A3 Diagnostics and therapeutics for macular degeneration-related disorders |
| 08/12/2004 | WO2003039441A3 Unc-13 in the modulation of neurotransmission and secretion events |
| 08/12/2004 | WO2003037060A3 Compositions and methods for wt1 specific immunotherapy |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2003012032A3 Antisense modulation of p70 s6 kinase expression |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002071927A9 Diagnosis and treatment of skeletal degeneration conditions |
| 08/12/2004 | WO2002057408A3 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 08/12/2004 | US20040158879 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 08/12/2004 | US20040158046 Modified growth hormone |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040158041 Chemically modified G-CSF |
| 08/12/2004 | US20040158037 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and biologically active substances and therapeutics produced therewith |
| 08/12/2004 | US20040158036 Neuritogenic compound and uses thereof |
| 08/12/2004 | US20040158035 Substantially pure glycopeptide antibiotics AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5 |
| 08/12/2004 | US20040158034 Echinocandin process |
| 08/12/2004 | US20040157911 Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof |
| 08/12/2004 | US20040157875 1, 6-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/12/2004 | US20040157834 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 08/12/2004 | US20040157798 Drug for use in bone grafting |
| 08/12/2004 | US20040157791 Systemic immune activation method using nucleic acid-lipid complexes |
| 08/12/2004 | US20040157786 Taxol, Taxotere and their analogues, which possess noteworthy antitumour and antileukaemic properties, are especially useful in the treatment of cancers of the ovary, breast or lung |